- Cancer Types
Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Cancer A to Z - Cancer Treatment
Cancer Treatment
Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
- Risk and Prevention
- Cancer Drugs
- Support
Support
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
- Healthcare Professionals
- Clinical Trials
My Patient Treatment Binder
OncoLink Blogs
What's My Cancer Risk?
OncoPilot: Navigating Your Cancer Journey
Community Events Calendar
OncoLink eNews
Abramson Cancer CenterMonday, November 6, 2006
|
A Phase III Intergroup Trial (RTOG 97-04) of Adjuvant Pre- and Post-chemoradiation (CRT) 5-FU vs. Gemcitabine (G) for Resected Pancreatic Adenocarcionma
Presenter: Abrams, R et al.Presenter's Affiliation: University of Maryland School of MedicineType of Session: ScientificBackground Pancreatic cancer is a very difficult cancer to treat and cure A previously published phase II trial of... |
|
|
A Phase III Intergroup Trial (RTOG 97-04) of Adjuvant Pre- and Post-chemoradiation (CRT) 5-FU vs. Gemcitabine (G) for Resected Pancreatic Adenocarcionma
Intra-arterial vs. Intravenous Chemoradiation for Advanced Head and Neck Cancer, Early Results of a Multi-institutional Trial Locally advanced squamous cell head and neck cancer is often treated with a combination of cisplatin chemotherapy and... |
|
|
Accelerated Versus Conventional Fractionated Radiotherapy in Squamous Cell Carcinoma of the Head and Neck (SCCHN: A Randomized International Multicenter Trial with 908 Patients Conducted by the IAEA-ACC Study Group
Presenter: J. OvergaardPresenter's Affiliation: Aarhus University Hospital, DenmarkType of Session: ScientificBackground Multiple prospective randomized trials have suggested that accelerated fractionation schedules may increase the efficacy of... |
|
|
Impact of Radiation on Survival After Complete Resection of Non Small Cell Lung Cancer: Descriptive Analysis in the Randomized Adjuvant Chemotherapy Trial Anita 1
Presenter: Jean-Yves Douillard, M.D., Ph.D.Presenter's Affiliation: Centre Rene Gauducheau, FranceType of Session: PlenaryBackground Post-operative radiotherapy ( PORT ) in lung cancer is a controversial topic. The PORT Meta-analysis previously... |
|
|
Impact of Radiation on Survival After Complete Resection of Non-Small Cell Lung Cancer: Descriptive Analysis in the Randomized Adjuvant Chemotherapy Trial Anita 1
Impact of Radiation on Survival After Complete Resection of Non-Small Cell Lung Cancer: Descriptive Analysis in the Randomized Adjuvant Chemotherapy Trial Anita 1 This analysis was done on a study designed to look at the benefit of chemotherapy for... |
|
|
Intergroup RTOG 9811: Phase III Comparison of Chemoradiation With 5-FU and Mitomycin Vs. 5-FU and Cisplatin for Anal Canal Carcinoma: Impact on Disease-Free, Overall and Colostomy-Free Survival
Presenter: L.L. GundersonPresenter's Affiliation: Mayo Clinic Cancer Center ? Arizona, Scottsdale, AZType of Session: ScientificBackground Anal cancer is frequently a loco-regional disease The RTOG 8704/ECOG 1289 study showed the... |
|
|
Intra-arterial vs. Intravenous Chemoradiation for Advanced Head and Neck Cancer, Early Results of a Multi-institutional Trial
Presenter: C. R. N. Rasch, M.D., Ph.D.Presenter's Affiliation: NetherlandsType of Session: PlenaryBackground The addition of concurrent cisplatin-based chemotherapy to definitive radiotherapy for locally advanced squamous cell carcinoma of the head... |
|
|
Long-term Neck Control Rates After Complete Response to Chemoradiation in Patients with Advanced Head and Neck Cancer
Presenter: R. RenganPresenter's Affiliation: Memorial Sloan-Kettering Cancer CenterType of Session: ScientificBackground The indications for planned neck dissection in patients with advanced head and neck cancer who achieve a complete response... |
|
|
Long-Term Results of a Randomized Trial of Tamoxifen With or Without Radiation in Women Over 50 Years of Age With T1/2 N0 Breast Cancer
Presenter: A. FylesPresenter's Affiliation: Princess Margaret HospitalType of Session: ScientificBackground Multiple studies have attempted to define a population of women with early stage breast cancer in whom the inclusion of radiation as a... |
|
|
Long-Term Survival Results of a Phase III Intergroup Trial (RTOG 95-01) of Surgery Followed by Radiotherapy vs. Radiochemotherapy for Resectable High Risk Squamous Cell Carcinoma of the Head and Neck
Presenter: Jay S. Cooper, MDPresenter's Affiliation: Maimonides Cancer Center; NY, NYType of Session: ScientificBackground Preliminary results of this study suggested a benefit in locoregional control and disease-free survival in patients with... |
|
|
Long-term Toxicity Outcomes After High-Dose Conformal Radiotherapy for Clinically Localized Prostate Cancer
Presenter: A. ShippyPresenter's Affiliation: Memorial Sloan-Kettering Cancer CenterType of Session: ScientificBackground Higher doses of radiotherapy have been shown in prospective randomized trials to correlate with improved clinical outcomes... |
|
|
Motexafin Gadolinium (MGd) Combined With Prompt Whole Brain Radiation Therapy Prolongs Time to Neurologic Progression in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases: Results of a Randomized Phase 3 Trial
Presenter: M.P. MehtaPresenter's Affiliation: University of Wisconsin, Madison, WIType of Session: ScientificBackground Motexafin gadolinium (MGd) is a radiosensitizer that is MRI-detectable and selectively localizes in tumors. ... |
|
|
Phase III Randomized Study of Intensity Modulated Radiation Therapy vs. Standard Wedging Adjuvant Breast Radiotherapy
Presenter: Jean-Philippe Pignol, M.D.Presenter's Affiliation: Sunnybrook and Women's College Health Sciences Centre, Toronto , Ontario , CanadaType of Session: PlenaryBackground The current standard adjuvant treatment of localized breast cancer... |
|
|
The 2006 Worldwide Overview of the Effects of Local Treatments for Early Breast Cancer On Long-term Outcome? "Meta-analysis of the Randomized Trials of Radiotherapy After Mastectomy With Axillary Clearance"
Presenter: Paul McGale, PhDPresenter's Affiliation: Clinical Trial Service Unit, United KingdomType of Session: PlenaryBackground Randomized trials have shown that post-mastectomy radiation therapy ( PMRT ) confers both a local control and... |
|
|
The 2006 Worldwide Overview of the Effects of Local Treatments for Early Breast Cancer On Long-term Outcome? "Meta-analysis of the Randomized Trials of Radiotherapy After Mastectomy With Axillary Clearance"
The 2006 Worldwide Overview of the Effects of Local Treatments for Early Breast Cancer On Long-term Outcome? "Meta-analysis of the Randomized Trials of Radiotherapy After Mastectomy With Axillary Clearance" It is well understood that... |
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
